Cargando…
Towards the development of novel Trypanosoma brucei RNA editing ligase 1 inhibitors
BACKGROUND: Trypanosoma brucei (T. brucei) is an infectious agent for which drug development has been largely neglected. We here use a recently developed computer program called AutoGrow to add interacting molecular fragments to S5, a known inhibitor of the validated T. brucei drug target RNA editin...
Autores principales: | Durrant, Jacob D, McCammon, J Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196686/ https://www.ncbi.nlm.nih.gov/pubmed/21878090 http://dx.doi.org/10.1186/1471-2210-11-9 |
Ejemplares similares
-
Novel Naphthalene-Based Inhibitors of Trypanosoma brucei RNA Editing Ligase 1
por: Durrant, Jacob D., et al.
Publicado: (2010) -
Functional and Structural Insights Revealed by Molecular Dynamics Simulations of an Essential RNA Editing Ligase in Trypanosoma brucei
por: Amaro, Rommie E., et al.
Publicado: (2007) -
Computer-Aided Identification of Trypanosoma brucei Uridine Diphosphate Galactose 4′-Epimerase Inhibitors: Toward the Development of Novel Therapies for African Sleeping Sickness
por: Durrant, Jacob D., et al.
Publicado: (2010) -
The Molecular Dynamics of Trypanosoma brucei UDP-Galactose 4′-Epimerase: A Drug Target for African Sleeping Sickness
por: Friedman, Aaron J, et al.
Publicado: (2012) -
Mutational Analysis of Trypanosoma brucei RNA Editing Ligase Reveals Regions Critical for Interaction with KREPA2
por: Mehta, Vaibhav, et al.
Publicado: (2015)